ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

A-JMRHS . 2023; 1(3): 60-65


Macular oedema in Rural Central Indian population- Etiology, Visual impact and associations and outcome of treatment.

BODHRAJ DHAWAN, VAISHALI DHAWAN, Anand Saraswat.



Abstract
Download PDF Cited by 0 ArticlesPost

BACKGROUND- Macular edema is a result of diverse etiologies, Diabetes and Hypertension being the most prominent, manifesting as Diabetic Macular edema and macular edema secondary to retinal vein occlusion. Present study aims to evaluate the causes, visual impact and associations of macular edema and outcome of treatment, in rural Indian Population. METHODS- This prospective evaluation is based on evaluation of 100 consecutive patients of Macular edema, aged 18 years or more, presenting to a tertiary care ophthalmic facility. They were ophthalmologically evaluated and treated as per established protocols. RESULTS- Mean age in the study population with macular edema was 55.20 ± 7.84 years; with Male to female ratio of 2.44:1. Diabetic retinopathy (seen in 58%) eyes was commonest cause of macular edema, followed by RVO (seen in 20%) of eyes. 92% of the patients received intra -vitreal injections for the treatment of macular oedema. Additional laser photocoagulation for co- existent diabetic retinopathy as an additional treatment was done in 48% of the cases and 5% received surgical treatment in form of vitrectomy. Pre treatment visual acuity was 6/18 to 6/36 in 40%, 6/60 in 19% and

Key words: Macular edema. Diabetic retinopathy, Retinal vein Occlusion, Anti VEGF therapy







Bibliomed Article Statistics

24
24
41
50
28
19
23
33
31
23
27
9
R
E
A
D
S

19

17

23

137

16

15

13

11

12

27

23

5
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.